234 related articles for article (PubMed ID: 16517326)
1. Duration of effects of aspirin on platelet function in healthy volunteers: an analysis using the PFA-100.
Konrad CJ; Schuepfer GK; Gerber H; Rukwied R; Schmelz M; Schley M
J Clin Anesth; 2006 Feb; 18(1):12-7. PubMed ID: 16517326
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100).
Feuring M; Haseroth K; Janson CP; Falkenstein E; Schmidt BM; Wehling M
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):584-8. PubMed ID: 10599950
[TBL] [Abstract][Full Text] [Related]
3. PFA-100 system: a new method for assessment of platelet dysfunction.
Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
Semin Thromb Hemost; 1998; 24(2):195-202. PubMed ID: 9579642
[TBL] [Abstract][Full Text] [Related]
4. Effects of aspirin and clopidogrel in healthy men measured by platelet aggregation and PFA-100.
Madsen EH; Schmidt EB; Maurer-Spurej E; Kristensen SR
Platelets; 2008 Aug; 19(5):335-41. PubMed ID: 18791939
[TBL] [Abstract][Full Text] [Related]
5. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
6. Use of the platelet function analyser (PFA-100) to quantify the effect of low dose aspirin in patients with ischaemic heart disease.
Coakley M; Self R; Marchant W; Mackie I; Mallett SV; Mythen M
Anaesthesia; 2005 Dec; 60(12):1173-8. PubMed ID: 16288614
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
8. Effect of increasing doses of aspirin on platelet function as measured by PFA-100 in patients with diabetes.
Abaci A; Yilmaz Y; Caliskan M; Bayram F; Cetin M; Unal A; Cetin S
Thromb Res; 2005; 116(6):465-70. PubMed ID: 16181981
[TBL] [Abstract][Full Text] [Related]
9. Duration of increased bleeding tendency after cessation of aspirin therapy.
Cahill RA; McGreal GT; Crowe BH; Ryan DA; Manning BJ; Cahill MR; Redmond HP
J Am Coll Surg; 2005 Apr; 200(4):564-73; quiz A59-61. PubMed ID: 15804471
[TBL] [Abstract][Full Text] [Related]
10. Monitoring aspirin therapy with the Platelet Function Analyzer-100.
Mortensen J; Poulsen TS; Grove EL; Refsgaard J; Nielsen HL; Pedersen SB; Thygesen SS; Hvas AM; Kristensen SD
Scand J Clin Lab Invest; 2008; 68(8):786-92. PubMed ID: 18651324
[TBL] [Abstract][Full Text] [Related]
11. Cross validation of the Multiple Electrode Aggregometry. A prospective trial in healthy volunteers.
Siller-Matula JM; Gouya G; Wolzt M; Jilma B
Thromb Haemost; 2009 Aug; 102(2):397-403. PubMed ID: 19652892
[TBL] [Abstract][Full Text] [Related]
12. Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.
Lev EI; Ramabadran RS; Guthikonda S; Patel R; Kleiman A; Granada JF; DeLao T; Kleiman NS
Am J Cardiol; 2007 Jan; 99(1):124-8. PubMed ID: 17196475
[TBL] [Abstract][Full Text] [Related]
13. Using the Platelet Function Analyzer-100 for monitoring aspirin therapy.
Poulsen TS; Mickley H; Korsholm L; Licht PB; Haghfelt T; Jørgensen B
Thromb Res; 2007; 120(2):161-72. PubMed ID: 17052745
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial.
Tang YD; Rinder HM; Katz SD
Am Heart J; 2007 Sep; 154(3):494.e1-7. PubMed ID: 17719296
[TBL] [Abstract][Full Text] [Related]
15. Cross validation of aspirin effect in healthy individuals by Impact-R and PFA-100: a double blind randomized placebo controlled trial.
Gouya G; Jilma B; Niel M; Eichelberger B; Wolzt M; Panzer S
Platelets; 2009 May; 20(3):171-6. PubMed ID: 19437334
[TBL] [Abstract][Full Text] [Related]
16. Platelet aggregation under high shear conditions during and after a 28-day administration of 100 mg acetylsalicylic acid in healthy volunteers.
Tschopp M; Reinhart WH
Clin Hemorheol Microcirc; 2008; 38(1):45-50. PubMed ID: 18094457
[TBL] [Abstract][Full Text] [Related]
17. Monitoring aspirin treatment in patients with thrombocytosis: comparison of the platelet function analyzer (PFA)-100 with optical aggregometry.
Tsantes AE; Mantzios G; Giannopoulou V; Tsirigotis P; Bonovas S; Rapti E; Mygiaki E; Kartasis Z; Sitaras NM; Dervenoulas J; Travlou A
Thromb Res; 2008; 123(1):100-7. PubMed ID: 18430462
[TBL] [Abstract][Full Text] [Related]
18. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
[TBL] [Abstract][Full Text] [Related]
19. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
Cesar JM; de Miguel D; García Avello A; Burgaleta C
Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
[TBL] [Abstract][Full Text] [Related]
20. [Acetylsalicylic acid (ASA) resistance in patients with ischemic heart disease (IHD) as bioindicator of the treatment strategy].
Malý J; Pecka M; Gregor J; Dulícek P; Blazek M; Malý R; Pudil R; Bláha M
Cas Lek Cesk; 2005; 144 Suppl 3():23-9. PubMed ID: 16335259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
